An Open-Label Study of YM087 (Conivaptan) in Patients With Euvolemic or Hypervolemic Hyponatremia

Mise à jour : Il y a 4 ans
Référence : NCT00379847

Femme et Homme

Extrait

This study will investigate the application of a vasopressin antagonist in the treatment of hyponatremia most likely caused by inappropriate AVP secretion. The population studied will include patients with euvolemic or hypervolemic hyponatremia.


Critère d'inclusion

  • Hyponatremia

Liens